Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability
Yue Ma(University of Technology Sydney), Deborah J. Marsh(University of Technology Sydney)
Cited by 0
Related Papers
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
|Endocrine Related Cancer|2010|127
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine
|Frontiers in Bioengineering and Biotechnology|2022|57
PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer
|International Journal of Molecular Sciences|2021|12